Wierzycka’s Sygnia in talks with India to develop new Covid-19 vaccine, Cabinet hears – News24

SA financial services company Sygnia is in talks with the Serum Institute of India about developing a new vaccine, conducting a trial and securing 10 million doses of it for South Africa, according to a presentation made to Parliament.

  • SA is in talks to buy additional doses of Johnson & Johnson’s Covid-19 vaccine and has been offered supplies of Russia’s Sputnik V shot.
  • Sygnia is in talks with the Serum Institut…

    See this full article at News24

    Other news: